Tech Company Financing Transactions
Matrix Genetics Funding Round
Private investors participated in a $1.6 million capital raise for Matrix Genetics. The financing round was announced by the company on 12/16/2015.
Transaction Overview
Company Name
Announced On
12/16/2015
Transaction Type
Debt
Amount
$1,600,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.
Company Information
Company Status
Private & Independent
Industry
Clean Tech
Mailing Address
1600 Fairview Ave. E 300
Seattle, WA 98102
USA
Seattle, WA 98102
USA
Phone
Website
Email Address
Not Recorded
Overview
Matrix Genetics is a biotechnology company focused on producing renewable fuel and specialty chemicals derived from cyanobacteria (blue-green algae).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Margaret McCormick
Chief Scientific Officer
James Roberts
Browse more venture capital transactions:
Prev: 12/16/2015: Rockland Technimed venture capital transaction
Next: 12/16/2015: Azalead venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs